Philanthropy & Grantmaking
(T30Z)
IRS Verified
DX Registered
990 on File
WBCS INC
Financial strength (30%)
76/100
Reliability (20%)
55/100
Effectiveness (25%)
83/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Founded in 1998 as the Wisconsin Breast Cancer Showhouse, WBCS, Inc.'s mission is to fund promising breast cancer and prostate cancer research at an early stage, when other support is often unavailable. An all-volunteer, 501(c)(3) charity, the organization has become the largest annual philanthropic donor for adult cancer research at the Medical College of Wisconsin. WBCS has donated more than $6.8 million to MCW for promising research and to endow the WBCS Professor of Breast Cancer Research. In October of 2017, WBCS committed to fund a $1 million Prostate Cancer Research Professorship at MCW.
Financial Overview — FY 2024
$232K
Total Revenue
$346K
Total Expenses
$425K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
94.0%
Fundraising Efficiency
3.5%
Operating Reserve
14.76x
Liability-to-Asset
0.0%
Revenue Diversification
86.2%
Compared with Peers
FY 2024
Compared with 16,669 similar organizations
(United States, Philanthropy & Grantmaking, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
94.0% | 90.2% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
5.6% | 7.9% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.5% | 0.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
3.5% | 7.3% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
14.8 mo | 95.2 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
86.2% | 90.5% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-5.1% | 18.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
1226.5% | 6.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-49.2% | 1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $232K | $346K | $425K | 94.0% | 0 |
| 2023 | $244K | $26K | $539K | 0.0% | 0 |
| 2022 | $431K | $382K | $321K | 91.6% | 0 |
| 2021 | $336K | $18K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.